Adapting motivational interventions for comorbid schizophrenia and alcohol use disorders

Clinical Psychology: Science and Practice

Volumn 14, Issue 1, 2007, Pages 39-57

  Carey, Kate B ^a   Leontieva, Luba ^b   Dimmock, Jacqueline ^b   Maisto, Stephen A ^a   Batki, Steven L ^b  

^a SYRACUSE UNIVERSITY   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Alcohol use disorder; Comorbidity; Motivational interventions; Schizophronia

Indexed keywords

NALTREXONE; PLACEBO;

ALCOHOL CONSUMPTION; ALCOHOLISM; AWARENESS; BEHAVIOR THERAPY; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; DISEASE SEVERITY; HUMAN; INTERPERSONAL COMMUNICATION; MOTIVATION; OUTPATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PSYCHOLOGIC TEST; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SELF CONCEPT; SOCIAL ADAPTATION; SYMPTOM;

EID: 33847658259     PISSN: 09695893     EISSN: 14682850     Source Type: Journal    
DOI: 10.1111/j.1468-2850.2007.00061.x     Document Type: Review

References (46)

1. Amrhein, P. C. (2004). How does motivational interviewing work? What client talk reveals. Journal of Cognitive Psychotherapy, 18, 323-336.
2. Amrhein, P. C., Miller, W. R., Yahne, C. E., Palmer, M., & Fulcher, L. (2003). Client commitment language during motivational interviewing predicts drug use outcomes. Journal of Consulting and Clinical Psychology, 71, 862-878.
3. Bandura, A. (1997). Self-efficacy: The exercise of control. New York: W. H. Freeman.
4. Barrowclough, C., Haddock, G., Tarrier, N., Lewis, S. W., Moring, J., O'Brien, R., et al. (2001). Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry, 158, 1706-1713.
5. Batki, S. L. (2006). Naltrexone Treatment of Alcohol Abuse in Schizophrenia. National Institute on Alcohol Abuse and Alcoholism grant R01 AA013655.
6. Bellack, A. S., Bennett, M. E., Gearon, J. S., Brown, C. H., & Yang, Y. (2006). A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry, 63, 426-432.
7. Bellack, A. S., & DiClemente, C. C. (1999). Treating substance abuse among patients with schizophrenia. Psychiatric Services, 50, 75-80.
8. Blanchard, J. J., Mueser, K. T., & Bellack, A. S. (1998). Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophrenia Bulletin, 24, 413-424.
9. Broome, K. M., Flynn, P. M., & Simpson, D. D. (1999). Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research, 34, 791-806.
10. Carey, K. B. (1996). Substance use reduction in the context of outpatient psychiatric treatment: A collaborative, motivational, harm reduction approach. Community Mental Health Journal, 32, 291-306.
11. Carey, K. B., Carey, M. P., Maisto, S. A., & Purnine, D. M. (2002). The feasibility of enhancing psychiatric outpatients' readiness to change their substance use. Psychiatric Services, 53, 602-608.
12. Carey, K. B., Maisto, S. A., Carey, M. P., & Purnine, D. M. (2001). Measuring readiness-to-change substance misuse among psychiatric outpatients I. Reliability and validity of self-report measures. Journal of Studies on Alcohol, 62, 79-88.
13. Carey, K. B., Purnine, D. M., Maisto, S. A., & Carey, M. P. (2001). Enhancing readiness-to-change substance abuse in persons with schizophrenia. A four-session motivation-based intervention. Behavior Modification, 25, 331-384.
14. Carey, K. B., Purnine, D. M., Maisto, S. A., Carey, M. P., & Barnes, K. L. (1999). Decisional balance regarding substance use among persons with schizophrenia. Community Mental Health Journal, 35, 289-299.
15. Center for Substance Abuse Treatment. (1998). Naltrexone and alcoholism treatment. Treatment Improvement Protocol (TIP) Series 28. DHHS Pub. No. (SMA) 98-3206. Washington, DC: U.S. Government Printing Office.
16. Center for Substance Abuse Treatment. (1999). Enhancing motivation for change in substance abuse treatment. Treatment Improvement Protocol (TIP) Series 35. DHHS Pub. No. (SMA) 99-3354. Washington, DC: U.S. Government Printing Office.
17. Clifford, P. R., & Maisto, S. A. (2000). Subject reactivity effects and alcohol treatment outcome research. Journal of Studies on Alcohol, 61, 787-793.
18. Corrigan, P. W. (2002). Empowerment and serious mental illness: Treatment partnerships and community opportunities. Psychiatric Quarterly, 73, 217-228.
19. Daley, D. C., Salloum, I. M., Zuckoff, A., Kirisci, L., & Thase, M. E. (1998). Increasing treatment adherence among outpatients with depression and cocaine dependence: Results of a pilot study. American Journal of Psychiatry, 155, 1611-1613.
20. Drake, R. E., Essock, S. M., Shaner, A., Carey, K. B., Minkoff, K., Kola, L., et al. (2001). Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services, 52, 469-476.
21. Emmons, R. A. (1986). Personal strivings: An approach to personality and subjective well-being. Journal of Personality and Social Psychology, 51, 1058-1068.
22. Graeber, D. A., Moyers, T. B., Griffith, G., Guajardo, E., & Tonigan, S. (2003). A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal, 39, 189-202.
23. Haywood, T. W., Kravitz, H. M., Grossman, L. S., Cavanaugh, J. L., Jr., Davis, J. M., & Lewis, D. A. (1995). Predicting the "revolving door"phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. American Journal of Psychiatry, 152, 856-861.
24. Hulse, G. K., & Tait, R. J. (2002). Six-month outcomes associated with a brief alcohol intervention for adult in-patients with psychiatric disorders. Drug and Alcohol Review, 21, 105-112.
25. Janis, I., & Mann, L. (1977). Decision making. New York: Free Press.
26. Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry, 66, 17-31.
27. Lambert, M. J. (2003). Bergin and Garfield's handbook of psychotherapy and behavior change (5th ed.). Hoboken, NJ: Wiley.
28. Maisto, S. A., Conigliaro, J., McNeil, M., Kraemer, K., Conigliaro, R. L., & Kelley, M. E. (2001). Effects of two types of brief intervention and readiness to change on alcohol use in hazardous drinkers. Journal of Studies on Alcohol, 62, 605-614.
29. Martino, S., Carroll, K. M., O'Malley, S. S., & Rounsaville, B. J. (2000). Motivational interviewing with psychiatrically ill substance abusing patients. American Journal of Addiction, 9, 88-91.
30. Miller, W. R. (1985). Motivation for treatment: A review with special emphasis on alcoholism. Psychological Bulletin, 98, 84-107.
31. Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change (2nd ed.). New York: Guilford.
32. Miller, W. R., Zweben, A., DiClemente, C. C., & Rychtarik, R. G. (1992). Motivational enhancement therapy manual. Washington, DC: U.S. Government Printing Office.
33. Minkoff, K. (2001). Developing standards of care for individuals with co-occurring psychiatric and substance use disorders. Psychiatric Services, 52, 597-599.
34. Olfson, M., Mechanic, D., Hansell, S., Boyer, C. A., Walkup, J., & Weiden, P. J. (2000). Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services, 51, 216-222.
35. Owen, R. R., Fischer, E. P., Booth, B. M., & Cuffel, B. J. (1996). Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services, 47, 853-858.
36. Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992). In search of how people change: Applications to addictive behaviors. American Psychologist, 47, 1102-1114.
37. Rollnick, S., Mason, P., & Butler, C. (1999). Health behavior change: A guide for practitioners. London: Churchill Livingstone.
38. Simons, J. S., & Carey, K. B. (2003). Personal strivings and marijuana use initiation, frequency, and problems. Addictive Behaviors, 28, 1311-1322.
39. Sobell, M. B., & Sobell, L. C. (1993). Problem drinkers: Guided self-change treatment. New York: Guilford.
40. Strecher, V. J., Seijts, G. H., Kok, G. J., Latham, G. P., Glasgow, R., DeVellis, B., et al. (1995). Goal setting as a strategy for health behavior change. Health Education Quarterly, 22, 190-200.
41. Swanson, A. J., Pantalon, M. V., & Cohen, K. R. (1999). Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease, 187, 630-635.
42. Swofford, C. D., Kasckow, J. W., Scheller-Gilkey, G., & Inderbitzin, L. B. (1996). Substance use: A powerful predictor of relapse in schizophrenia. Schizophrenia Research, 20, 145-151.
43. The COMBINE Study Research Group. (2003). Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: Rationale and methods. Alcoholism: Clinical and Experimental Research, 27, 1107-1122.
44. Walters, S. T., & Neighbors, C. (2005). Feedback interventions for college alcohol misuse: What, why and for whom? Addictive Behaviors, 30, 1168-1182.
45. Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44, 660-669.
46. Ziedonis, D. M., Smelson, D., Rosenthal, R. N., Batki, S. L., Green, A. I., Henry, R. J., et al. (2005). Improving the care of individuals with schizophrenia and substance use disorders: Consensus recommendations. Journal of Psychiatric Practice, 11, 315-339.